PNC Financial Services Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-327
Closed -$264 4942
2025
Q1
$264 Buy
327
+229
+234% +$185 ﹤0.01% 4742
2024
Q4
$135 Hold
98
﹤0.01% 4692
2024
Q3
$102 Sell
98
-176
-64% -$183 ﹤0.01% 4723
2024
Q2
$474 Sell
274
-408
-60% -$706 ﹤0.01% 4542
2024
Q1
$1.63K Buy
682
+128
+23% +$306 ﹤0.01% 4254
2023
Q4
$1.85K Sell
554
-4,003
-88% -$13.3K ﹤0.01% 4210
2023
Q3
$17K Buy
4,557
+2,318
+104% +$8.67K ﹤0.01% 3505
2023
Q2
$9.56K Sell
2,239
-1,469
-40% -$6.27K ﹤0.01% 3892
2023
Q1
$25.4K Sell
3,708
-5,722
-61% -$39.1K ﹤0.01% 3380
2022
Q4
$74.7K Sell
9,430
-127
-1% -$1.01K ﹤0.01% 2750
2022
Q3
$91K Sell
9,557
-2,801
-23% -$26.7K ﹤0.01% 2595
2022
Q2
$88K Buy
12,358
+6,245
+102% +$44.5K ﹤0.01% 2659
2022
Q1
$79K Sell
6,113
-2,016
-25% -$26.1K ﹤0.01% 2843
2021
Q4
$129K Buy
8,129
+3,614
+80% +$57.4K ﹤0.01% 2519
2021
Q3
$72K Buy
4,515
+1,367
+43% +$21.8K ﹤0.01% 2838
2021
Q2
$44K Buy
3,148
+969
+44% +$13.5K ﹤0.01% 3134
2021
Q1
$32K Buy
2,179
+247
+13% +$3.63K ﹤0.01% 3207
2020
Q4
$34K Sell
1,932
-609
-24% -$10.7K ﹤0.01% 3113
2020
Q3
$47K Buy
2,541
+733
+41% +$13.6K ﹤0.01% 2771
2020
Q2
$34K Buy
1,808
+444
+33% +$8.35K ﹤0.01% 2968
2020
Q1
$22K Sell
1,364
-70
-5% -$1.13K ﹤0.01% 3057
2019
Q4
$26K Sell
1,434
-68,152
-98% -$1.24M ﹤0.01% 3210
2019
Q3
$1.41M Sell
69,586
-27,668
-28% -$561K ﹤0.01% 1121
2019
Q2
$2.15M Buy
+97,254
New +$2.15M ﹤0.01% 986
2015
Q1
Sell
-7,580
Closed -$124K 4698
2014
Q4
$124K Buy
+7,580
New +$124K ﹤0.01% 2352